Senhwa Biosciences, Inc. announced that the U.S. FDA has granted Orphan Drug Designation to CX-4945 for the treatment of cholangiocarcinoma....
Read more
Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known...
Read moreThe US FDA has approved Synjardy® XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When...
Read moreSun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) and Israel-based Moebius Medical have entered into an exclusive...
Read moreRespiratorius AB (publ.) has received Orphan Drug Designation for its drug candidate VAL001 following a decision by the European Commission....
Read moreNovo Nordisk A/S said the U.S. FDA approved on Monday its diabetes drug, Xultophy.The Danish drug maker said it planned...
Read moreArog Pharmaceuticals, Inc , a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to...
Read moreSanofi announced that the U.S. FDA approved once-daily Soliqua 100/33 100 Units/mL & 33 mcg/mL for the treatment of adults...
Read moreSandoz, a Novartis company, has announced its drug, Erelzi, has been approved by the FDA, in a significant development. ...
Read moreTeva Pharmaceutical Industries Ltd announced it has obtained approval from the European Commission for an indication extension of Trisenox® (arsenic...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
